Provided by Tiger Trade Technology Pte. Ltd.

Ionis Pharmaceuticals

43.30
-0.8600-1.95%
Pre-market: 43.450.1500+0.35%09:15 EDT
Volume:3.35M
Turnover:145.42M
Market Cap:7.20B
PE:-12.44
High:44.19
Open:43.76
Low:42.79
Close:44.16
52wk High:86.74
52wk Low:42.63
Shares:166.18M
Float Shares:161.92M
Volume Ratio:1.36
T/O Rate:2.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.4800
EPS(LYR):-2.3812
ROE:-105.50%
ROA:-12.42%
PB:16.36
PE(LYR):-18.18

Loading ...

Aug 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 30, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 30, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jul 30, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 30, 2025

Major Issues Report

Form 8-K - Current report
Jun 12, 2025

Major Issues Report

Form 8-K - Current report
Jun 10, 2025

Major Issues Report

Form 8-K - Current report
May 19, 2025

Major Issues Report

Form 8-K - Current report
Apr 30, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 30, 2025

Major Issues Report

Form 8-K - Current report
Apr 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 12, 2025

Major Issues Report

Form 8-K - Current report
Mar 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 20, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 19, 2025

Major Issues Report

Form 8-K - Current report
Feb 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities